Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
CoStim Pharmaceuticals Inc. operates as a biotechnology company. It develops antibody agents for treatment of cancer. The company was
Kalidex Pharmaceuticals develops quinolones to fight infections caused by multi-drug resistant organisms.
MPM Capital has invested in 50 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
MPM Capital's top investment sectors include Biotechnology, Manufacturing, Pharmaceutical. The firm invests across 3 different industry categories.
Among tracked funding rounds, CoStim Pharmaceuticals received $22.0M in a Series A round. MPM Capital's total known invested capital is $3.8B.
MPM Capital's average investment size is $101.2M across its portfolio of 50 companies.